A child with Henoch-Schonlein purpura secondary to a COVID-19 infection

Area of Science:

• Pediatric Rheumatology
• Infectious Diseases
• Immunology

Background:

• Henoch-Schonlein purpura (HSP) is a prevalent IgA-mediated small vessel vasculitis in children, presenting with multi-system involvement.
• HSP is characterized by a tetrad of symptoms: rash, arthritis, abdominal pain, and kidney disease.
• Potential triggers for HSP include infections, medications, vaccinations, and malignancies.

Observation:

• A 4-year-old boy presented with clinical manifestations consistent with HSP.
• The patient had a recent history of recovering from a COVID-19 upper respiratory tract infection.
• COVID-19 (caused by SARS-CoV-2) is known for respiratory symptoms and has been associated with various extrapulmonary complications.

Findings:

• This case suggests a potential association between recent COVID-19 infection and the subsequent development of HSP in a pediatric patient.
• The temporal relationship between SARS-CoV-2 infection and HSP onset warrants further investigation.
• The findings contribute to understanding the diverse clinical spectrum of post-infectious complications of COVID-19.

Implications:

• This case underscores the importance of considering recent viral infections, including COVID-19, as potential triggers for HSP in children.
• Further research is needed to elucidate the immunological mechanisms linking SARS-CoV-2 infection to vasculitis.
• Recognizing this association can aid in earlier diagnosis and management of HSP in the context of the COVID-19 pandemic.